Journal
CURRENT HIV/AIDS REPORTS
Volume 18, Issue 6, Pages 527-537Publisher
SPRINGER
DOI: 10.1007/s11904-021-00584-9
Keywords
HIV; SIV; Non-human primate; Microbiome; Dysbiosis
Categories
Funding
- Division of Intramural Research/NIAID/NIH
Ask authors/readers for more resources
In the NHP model, observations of differing bacterial and intestinal microbiomes following SIV infection are inconsistent, and clear experimental assessments are lacking. Despite compelling associations, the defined contributions of the microbiome to HIV and SIV disease remain unclear.
Purpose of Review Observations of differing bacterial, intestinal microbiomes in people living with HIV have propelled interest in contributions of the microbiome to HIV disease. Non-human primate (NHP) models of HIV infection provide a controlled setting for assessing contributions of the microbiome by standardizing environmental confounders. We provide an overview of the findings of microbiome contributions to aspects of HIV disease derived from these animal models. Recent Findings Observations of differing bacterial, intestinal microbiomes are inconsistently observed in the NHP model following SIV infection. Differences in lentiviral susceptibility and vaccine efficacy have been attributed to variations in the intestinal microbiome; however, by-and-large, these differences have not been experimentally assessed. Although compelling associations exist, clearly defined contributions of the microbiome to HIV and SIV disease are lacking. The empirical use of comprehensive multi-omics assessments and longitudinal and interventional study designs in NHP models is necessary to define this contribution more clearly.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available